209 related articles for article (PubMed ID: 31295207)
1. Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery.
Rousset F; Kokje VBC; Coelho MDC; Mugnier T; Belissa E; Gabriel D; Gurny R; Krause KH; Senn P
Otol Neurotol; 2019 Aug; 40(7):e739-e746. PubMed ID: 31295207
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
3. [Intratympanic dexamethasone vesus post-auricular subperiosteal injection of methylprednisolone treatment for sudden hearing loss].
Li DB; Zhou S; Xu WJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(16):1265-1268. PubMed ID: 29798375
[No Abstract] [Full Text] [Related]
4. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
Gouveris H; Selivanova O; Mann W
Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
[TBL] [Abstract][Full Text] [Related]
5. Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss.
Plontke SK; Glien A; Rahne T; Mäder K; Salt AN
Otol Neurotol; 2014 Aug; 35(7):1168-71. PubMed ID: 24841917
[TBL] [Abstract][Full Text] [Related]
6. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.
Suzuki H; Koizumi H; Ohkubo J; Hohchi N; Ikezaki S; Kitamura T
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic dexamethasone for managing pregnant women with sudden hearing loss.
Fu Y; Jing J; Ren T; Zhao H
J Int Med Res; 2019 Jan; 47(1):377-382. PubMed ID: 30328358
[TBL] [Abstract][Full Text] [Related]
8. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment.
Dispenza F; De Stefano A; Costantino C; Marchese D; Riggio F
Am J Otolaryngol; 2013; 34(4):296-300. PubMed ID: 23357592
[TBL] [Abstract][Full Text] [Related]
9. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
Sun RX; Zhao Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066
[No Abstract] [Full Text] [Related]
10. Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial.
Chang WT; Zee B; Lee HSH; Tong MCF
Am J Otolaryngol; 2020; 41(4):102515. PubMed ID: 32487334
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
13. Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.
Kara E; Cetik F; Tarkan O; Sürmelioğlu O
Eur Arch Otorhinolaryngol; 2010 May; 267(5):701-7. PubMed ID: 19862543
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia after intratympanic dexamethasone treatment in a diabetic patient.
Gallegos-Constantino V; Cervera-Paz FJ; Salvador J; Ba FK; Perez-Fernandez N
Rev Laryngol Otol Rhinol (Bord); 2011; 132(3):153-5. PubMed ID: 22533068
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T
Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
Yoo MH; Lim WS; Park JH; Kwon JK; Lee TH; An YH; Kim YJ; Kim JY; Lim HW; Park HJ
Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach.
Wang X; Dellamary L; Fernandez R; Harrop A; Keithley EM; Harris JP; Ye Q; Lichter J; LeBel C; Piu F
Audiol Neurootol; 2009; 14(6):393-401. PubMed ID: 19923809
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Concurrent or Sequential Intravenous and Intratympanic Steroid for Idiopathic Sudden Sensorineural Hearing Loss.
Chu CH; Chiou SR; Wang MC; Shiao AS; Tu TY; Lin LY; Huang CY; Liao WH
Audiol Neurootol; 2018; 23(5):277-284. PubMed ID: 30537751
[TBL] [Abstract][Full Text] [Related]
20. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
Zhong SX; Zuo WQ; Zhang BY; Qian Y; Lei Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 53(11):806-810. PubMed ID: 30453397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
